Explore 3 Stock Ideas & Industry Insights Download Free Report

small-cap

Momentum Model Portfolio Rebalancing: EXIT (ASX: NVX) and ENTRY (ASX: CXL)

May 16, 2025 | Team Kalkine
Momentum Model Portfolio Rebalancing:  EXIT (ASX: NVX) and ENTRY (ASX: CXL)
Image source: shutterstock

  • NVX:ASX
  • Investment Type
    Small-Cap
  • Risk Level
  • Action
  • Rec. Price (AU$)
  • CXL:ASX
  • Investment Type
    Small-Cap
  • Risk Level
  • Action
  • Rec. Price (AU$)

Exit Case: NOVONIX Limited (ASX: NVX)

Overview: NOVONIX Limited (ASX: NVX) is a leading battery materials and technology company focused on advancing the global lithium-ion battery industry. The company specializes in developing high-performance materials, state-of-the-art testing equipment, and innovative solutions aimed at enhancing battery efficiency, lifespan, and environmental sustainability. NVX has been a part of the 'Momentum Model Portfolio' since May 12, 2025. Therefore, an 'Exit' stance from the Momentum Model Portfolio is recommended on the stock at the current market price of AUD 0.575 as on May 16, 2025, at 12:15 PM AEST.

NVX’s Daily Chart

New Entry Case: Calix Limited (ASX: CXL)

Overview: ​ ​ Calix Limited (ASX: CXL) is an Australian environmental technology company headquartered in Pymble, New South Wales. Established in 2005 and publicly listed on the Australian Securities Exchange in 2018, Calix focuses on developing and commercializing technologies aimed at addressing global challenges in industrial decarbonization and sustainability.

Technical Analysis: On the daily chart, CXL is trading above a key horizontal trendline support zone, signalling the potential for continued upward momentum. The 14-period Relative Strength Index (RSI) has climbed to around 65.50, reflecting strengthening bullish sentiment. Further supporting the positive technical outlook, the price has crossed above the 21-period Simple Moving Average (SMA), which now acts as a dynamic support level and may help sustain the current uptrend.

CXL is recommended as a new entry in the 'Momentum Model Portfolio' as on May 16, 2025. Considering the technical analysis, support and resistance levels, an 'Entry' is recommended in the 'Momentum Model Portfolio' at the current market price of AUD 0.475 as on May 16, 2025, at 12:15 PM AEST.

CXL’s Daily Chart

Support and Resistance Summary (As on May 16, 2025)

Note 1: Past performance is neither an Indicator nor a guarantee of future performance.

Note 2: The reference date for all price data, and currency as of May 16, 2025. The reference data in this report has been partly sourced from REFINITIV.

Note 3: Investment decisions should be made depending on an individual's appetite for upside potential, risks, holding duration, and any previous holdings.

Disclaimer

This information should not be relied upon as personal financial advice by Kalkine on (i) the stocks or (ii) the use or suitability of the model portfolios. Only an investor knows about their circumstances to make an investment decision.

Model Portfolio has been prepared for illustrative purpose only and does not take into account the objectives, financial situation or needs of any particular investor. Accordingly, investors should, before acting on the information, consider its appropriateness, having regard to their objectives, financial situation and needs. Past performance is not necessarily indicative of future performance results. Actual investment returns will vary, and the value of investments can go up or down.


Disclaimer-

Disclaimer This report has been issued by Kalkine New Zealand Limited (FSP691351) (NZBN:9429047678101) (“Kalkine”). Kalkine is a Financial Advice Provider (“FAP”) and is authorised by a Class 1 Financial Advice Provider Licence issued by Financial Markets Authority (“FMA”) to provide financial advice. Kalkine provides only general financial advice through its research reports following a person becoming a member. The reports contain buy/sell/hold and other recommendations in relation to equity securities, managed funds and other managed investment schemes and other financial advice products. The recommendations and opinions in this report and on Kalkine website do not take into account any of your investment objectives, financial situation or needs. Before you make a decision about whether to acquire a financial product, you should obtain the Product Disclosure Statement from the product issuer. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. If you act on the advice in the research reports, you may have to pay fees, expenses or other amounts (but not to Kalkine). Further information about the complaints and dispute resolution process, as well as information about Kalkine’s duties are available on Kalkine’s website. Please read our Financial Advice Provider (FAP) disclosure statement and Complaints Handling Guide, which are available on the website.

Past performance is not a reliable indicator of future performance.